Barry Badeau

Scientist at NeuBase Therapeutics - Pittsburgh, PA, US

Barry Badeau's Contact Details
HQ
N/A
Location
Company
NeuBase Therapeutics
Barry Badeau's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Barry Badeau
Barry Badeau currently works for NeuBase Therapeutics, Inc..
Barry Badeau's role at NeuBase Therapeutics, Inc. is Scientist.
Barry Badeau's email address is ***@neubasetherapeutics.com. To view Barry Badeau's full email address, please signup to ConnectPlex.
Barry Badeau works in the Pharmaceuticals industry.
Barry Badeau's colleagues at NeuBase Therapeutics are Ramesh Batwal, Zachary Miller, Rohan Kumbhare, Jessica Jeffers, Lyuqin Chen, Sally Edmonds, Sandra Rojas-Caro and others.
Barry Badeau's phone number is N/A
See more information about Barry Badeau